Home/Filings/4/0001209191-22-026091
4//SEC Filing

Lucas Svetlana 4

Accession 0001209191-22-026091

CIK 0001339970other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 7:50 PM ET

Size

5.5 KB

Accession

0001209191-22-026091

Insider Transaction Report

Form 4
Period: 2022-04-26
Transactions
  • Award

    Restricted Stock Units

    2022-04-26+6,0006,000 total
    Common Stock (6,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Issuer

aTYR PHARMA INC

CIK 0001339970

Entity typeother

Related Parties

1
  • filerCIK 0001781292

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 7:50 PM ET
Size
5.5 KB